The article discusses research aimed at the development of a universal influenza vaccine as of January 2014. Topics include mutations in influenza strains every season and the impact of new viruses such as H7N9 and H1N1, traditional vaccines' use of flu antigens, and the difficulty in obtaining funding for and approval of new flu vaccines.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados